These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 15914134

  • 1. Male tolerance of ACIDFORM gel.
    Schwartz JL, Poindexter A, Schmitz SW, Mauck C, Callahan MM.
    Contraception; 2005 Jun; 71(6):443-6. PubMed ID: 15914134
    [Abstract] [Full Text] [Related]

  • 2. Safety evaluation of 1% tenofovir gel in healthy men.
    Schwartz JL, Poindexter A, Wheeless A, Mauck CK, Callahan MM.
    Int J STD AIDS; 2009 Jun; 20(6):384-6. PubMed ID: 19451321
    [Abstract] [Full Text] [Related]

  • 3. Male tolerance study of 1% C31G.
    Mauck CK, Frezieres RG, Walsh TL, Schmitz SW, Callahan MM, Bax R.
    Contraception; 2004 Sep; 70(3):221-5. PubMed ID: 15325891
    [Abstract] [Full Text] [Related]

  • 4. Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y Jelly.
    von Mollendorf CE, Van Damme L, Moyes JA, Rees VH, Callahan MM, Mauck CK, Puren AJ, Tweedy K, Taylor D.
    Contraception; 2010 Mar; 81(3):232-9. PubMed ID: 20159180
    [Abstract] [Full Text] [Related]

  • 5. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
    Jespers V, Buvé A, Van Damme L.
    Sex Transm Dis; 2007 Jul; 34(7):519-22. PubMed ID: 17297382
    [Abstract] [Full Text] [Related]

  • 6. Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm.
    Williams DL, Newman DR, Ballagh SA, Creinin MD, Barnhart K, Weiner DH, Bell AJ, Jamieson DJ.
    Sex Transm Dis; 2007 Dec; 34(12):977-84. PubMed ID: 18080349
    [Abstract] [Full Text] [Related]

  • 7. Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
    Malonza IM, Mirembe F, Nakabiito C, Odusoga LO, Osinupebi OA, Hazari K, Chitlange S, Ali MM, Callahan M, Van Damme L.
    AIDS; 2005 Dec 02; 19(18):2157-63. PubMed ID: 16284466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.
    Mauck C, Weiner DH, Ballagh S, Creinin M, Archer DF, Schwartz J, Pymar H, Lai JJ, Callahan M.
    Contraception; 2001 Dec 02; 64(6):383-91. PubMed ID: 11834238
    [Abstract] [Full Text] [Related]

  • 15. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E, Perdigão A, Souza MH, Mauck C, Waller D, Zaneveld L, Faúndes A.
    Contraception; 2004 Dec 02; 70(6):492-7. PubMed ID: 15541412
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men.
    Tabet SR, Callahan MM, Mauck CK, Gai F, Coletti AS, Profy AT, Moench TR, Soto-Torres LE, Poindexter III AN, Frezieres RG, Walsh TL, Kelly CW, Richardson BA, Van Damme L, Celum CL.
    J Acquir Immune Defic Syndr; 2003 Aug 01; 33(4):476-83. PubMed ID: 12869836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.